GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Clinical trials for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS explained in plain language.
Never miss a new study
Get alerted when new GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS trials appear
Sign up with your email to follow new studies for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug may ease period problems in teens
Symptom relief ENROLLING_BY_INVITATIONThis study looks at how common irregular periods are in teen girls with type 1 diabetes and tests whether a glucagon-like peptide-1 (GLP-1) drug can help. About 50 girls aged 12 to 18 with poor blood sugar control will take the drug for 3 months. The goal is to see if their perio…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Phase: PHASE1, PHASE2 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated May 07, 2026 18:44 UTC
-
Popular Weight-Loss drugs may require longer Pre-Surgery fasting
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether people taking GLP-1 receptor agonists (like Ozempic or Wegovy) need a longer fast before surgery. These drugs slow down stomach emptying, which might increase the risk of food or liquid entering the lungs during anesthesia. Researchers will use ultraso…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Sponsor: Wael Saasouh, MD • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC